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Chrysophanic acid (CA) is a member of the anthraquinone family abundant in rhubarb,
a widely used herb for obesity treatment in Traditional Korean Medicine. Though
several studies have indicated numerous features of CA, no study has yet reported
the effect of CA on obesity. In this study, we tried to identify the anti-obesity effects of
CA. By using 3T3-L1 adipocytes and primary cultured brown adipocytes as in vitro
models, high-fat diet (HFD)-induced obese mice, and zebrafish as in vivo models,
we determined the anti-obesity effects of CA. CA reduced weight gain in HFD-
induced obese mice. They also decreased lipid accumulation and the expressions
of adipogenesis factors including peroxisome proliferator-activated receptor gamma
(PPARγ) and CCAAT/enhancer-binding protein alpha (C/EBPα) in 3T3-L1 adipocytes.
In addition, uncoupling protein 1 (UCP1) and peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC1α), the brown fat specific thermogenic genes, were
up-regulated in brown adipocytes by CA treatment. Furthermore, when co-treated with
Compound C, the AMP-activated protein kinase (AMPK) inhibitor, the action of CA on
AMPKα was nullified in both types of adipocytes, indicating the multi-controlling effect of
CA was partially via the AMPKα pathway. Given all together, these results indicate that
CA can ameliorate obesity by controlling the adipogenic and thermogenic pathway at
the same time. On these bases, we suggest the new potential of CA as an anti-obese
pharmacotherapy.
Keywords: chrysophanic acid, obesity, adipogenesis, thermogenesis, AMP-activated protein kinase alpha
INTRODUCTION
Obesity is a public health dilemma, especially in developed countries which has steadily increased
in recent years. The World Health Organization currently estimates that over one billion
individuals worldwide are overweight. Almost one-third of these individuals are clinically obese,
markedly raising their chances of cardiovascular disease, type 2 diabetes, cancer, and stroke
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(Waxman, 2004). Even more problematic is that about 25% of
children in the USA are also now overweight or obese. These
numbers are expected to increase by more than half again by
the year 2025 worldwide, with especially severe impact in less
developed countries (Haslam and James, 2005).
The regulation of body fat in animals results from the
integration of multiple nutrient, sensory, and hormonal inputs
primarily at the level of the brain and adipose tissues
(Farooqi and O’Rahilly, 2007). The mechanisms underlying the
development of obesity may include enzymatic/receptor and
hormonal changes (i.e., lipoprotein lipase, hormone sensitive
lipase, very low-density lipoprotein (VLDL) receptor, insulin,
growth hormone, catecholamine) in the skeletal muscles and
adipose tissues. This may result from physical inactivity and
inappropriate macronutrient intake (i.e., high levels of saturated
fat and/or refined carbohydrates), or both (Garrow, 1998). Thus,
the integrated network of obesity is influenced not only by
genetics but also by circadian rhythms, as well as physical and
social environments (Pospisilik et al., 2010).
Mammals have two types of adipose tissues, white adipose
tissues (WAT) and brown adipose tissues (BAT). These
two tissues have quite opposite roles in whole-body energy
metabolism; that is, WAT is for energy storage, and BAT is
for cold and diet-induced thermogenesis, which significantly
contributes to the control of body temperature and energy
expenditure (Cannon and Nedergaard, 2004). BAT, a site of non-
shivering thermogenesis, shows promise in combating obesity,
since it contributes to the regulation of whole-body energy
expenditure and body fat content in small rodents (Cannon
and Nedergaard, 2004). Recent studies using fluorodeoxyglucose-
PET in combination with CT revealed that adult humans have
considerable amounts of BAT (Cypess et al., 2009; Saito et al.,
2009; van Marken Lichtenbelt et al., 2009; Virtanen et al.,
2009). BAT thermogenesis is principally dependent on the
β-adrenergically mediated activation of lipolysis and subsequent
degradation of fatty acids via uncoupling protein 1 (UCP1),
which uncouples mitochondrial oxidative phosphorylation to
dissipate the electrochemical gradient as heat instead of ATP
synthesis. Thus, the β-adrenoceptor–UCP1 system has been
expected as an intriguing target for the control of whole-body
energy balance, adiposity, and obesity (Lowell and Bachman,
2003; Inokuma et al., 2006; Feldmann et al., 2009).
The 3T3-L1 adipocyte cell line is one of the most well-
characterized and reliable models of white adipocytes for
studying the conversion of preadipocytes into adipocytes.
Adipocytes differentiation is a complex process involving
coordinated expression of specific genes and proteins
associated with each stage of adipogenesis (Zhou et al., 2009).
Differentiation of 3T3-L1 preadipocytes into mature adipocytes
is induced by up stimulation with three differentiation inducers
(MDI); 3-isobutyl-1-methylxanthine (IBMX), dexamethasone
(Dex) and insulin, which promote the accumulation of
intracellular lipid droplets in mature adipocytes (Jessen
and Stevens, 2002). During adipogenesis of 3T3-L1 cells,
peroxisome proliferators activated receptor-γ (PPARγ) and
CCAAT/enhancer-binding protein-α (C/EBPα) play key
roles as major transcription factors (Lee et al., 2011). The
expressions of PPAR, a transcription factor of the nuclear-
receptor superfamily and C/EBPα, a member of C/EBP family
basic-leucine zipper class of transcription factors are increased
during differentiation of 3T3-L1 cells (Kwak et al., 2012).
Lipin is also a central regulator of adipose tissue development.
Mammalian lipin proteins have been shown to enzymatically
convert phosphatidate to diacylglycerol, an essential precursor
in triacylglycerol and phospholipid synthesis (Ugrankar et al.,
2011). A study by Zhang et al. (2012) established that the Lipin1
gene is required at an early step in adipocyte differentiation
for induction of the adipogenic gene transcription program,
including the key regualtor PPARγ.
AMP-activated protein kinase (AMPK), composed of α, β, and
γ subunits, is a “cellular fuel gage” which acts to simultaneously
shut down ATP-consuming biosynthetic processes and facilitate
ATP-producing catabolic processes during periods of metabolic
stress, leading to rapid changes in the control of fatty acid
metabolism. Thus, AMPK is a key player in energy homeostasis.
AMPK-derived stimulation of fatty acid metabolism occurs as
a result of AMPK phosphorylation (Kim and Choung, 2012).
AMPK is phosphorylated when the intracellular AMP/ATP ratio
increases because of metabolic stress. Subsequently, downstream
target molecules are activated, resulting in promotion of
catabolism. On the other hand, when the intracellular AMP/ATP
ratio decreases, AMPK increases anabolism. This key regulator
of energy homeostasis is also associated with adipocyte
differentiation in 3T3-L1 cells (Kim and Kong, 2010; Huang et al.,
2011).
Chrysophanic acid (CA) is a member of the anthraquinone
family. The results of previous pharmaceutical studies have
shown that derivatives of anthraquinones exert a number of
biological effects, including anticancer (Shoemaker et al., 2005;
Huang et al., 2007), hepatoprotective (Arosio et al., 2000),
antimicrobial (Fosse et al., 2004), and anti-inflammatory (Kim
et al., 2010). As several studies have indicated that obesity is
associated with a low-grade proinflammatory state (Weisberg
et al., 2003; Hajer et al., 2008), the anti-inflammatory feature
of CA suggests the possible use of CA in obesity-related issues.
In addition, several studies also report the use of rhubarb in
obesity care (Greenway et al., 2006; Amin and Nagy, 2009; Tseng
et al., 2011; Zhou et al., 2014), a herb which CA is one of
the active compounds (Liu et al., 2005). However, even though
numerous biological activities of CA have been reported, there
is only limited evidence for its anti-obesity effect. In this study,
we investigated how CA works on adipocyte differentiation
process at the molecular levels in 3T3-L1 adipocytes and primary
cultured brown adipocytes, and the in vivo effects of dietary
CA on body weight changes, physiological, histological, and
metabolic variables in high-fat diet (HFD)-fed C57BL/6J mice
were evaluated.
MATERIALS AND METHODS
Chemical Reagents
Chrysophanic acid (>98% pure) was purchased from Sigma
Chemicals (St. Louis, MO, USA) and was dissolved in 100%
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dimethyl sulfoxide (DMSO, Sigma Chemicals, St. Louis, MO,
USA). The Dulbecco’s modified Eagle’s medium (DMEM) and
penicillin-streptomycin were from Gibco BRL (Grand Island,
NY, USA). Fetal bovine serum (FBS) was from HyClone (Logan,
UT, USA). Antibodies for PPAR-γ, AMPKα, and p-AMPKα
were purchased from Cell Signaling Technology (Beverly, MA,
USA), antibodies for C/EBP-α, Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), and PPAR-γ coactivator 1-alpha
(PGC1α) were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA), and antibody for UCP1 was from Millipore
Corporation (Bedford, MA, USA).
Animals and Diets
Male 4-week-old C57BL/6J mice were purchased from Daehan
Biolink Co. (Eumsung, Korea) and maintained for 1 week prior to
experiments. Mice were maintained on a 12-h light/dark cycle in
a pathogen-free animal facility, provided with laboratory diet and
water ad libitum. All experimental protocols involving the use
of animals were conducted under approval of the Animal Care
and Use Committee of the Institutional Review Board of Kyung
Hee University (confirmation number : KHUASP(SE)-12-036).
To induce obesity, the mice were fed a HFD (Rodent diet D12492;
Research diet, New Brunswick, NJ, USA) with 60% kcal% fat.
Control group (C) were fed a commercial standard chow diet
(CJ Feed Co., Seoul, Korea). HFD group (HFD) mice were fed
with HFD only. HFD plus CA group (CA) Mice were fed with
HFD for 4 weeks before administration of CA (5 mg/kg/day). The
mice were divided into three groups (n = 5) that were fed chow
diet, HFD, and HFD plus CA for 16 weeks. Body weight and food
intake were measured three times per week.
Serum Analysis
Plasma was separated immediately after blood sampling by
centrifugation at 4,000 g for 30 min. Total cholesterol (TC),
high-density lipoprotein (HDL) cholesterol, LDL cholesterol,
triglyceride, glucose, aspartate aminotransferase (AST), and
alanine aminotransferase (ALT) were assessed using enzymatic
colorimetric methods performed by Seoul Medical Science
Institute (Seoul Clinical Laboratories, Seoul, Korea).
Hematoxylin and Eosin (H&E) Staining
After the mice were sacrificed, the white fat tissues, brown fat
tissues and liver tissues were collected, washed in saline and
fixed in 10% formalin. The formalin-fixed, paraffin-embedded
prostate specimens were cut into 4-µm-thick tissue sections.
These sections were deparaffinized in xylene and rehydrated in
serial alcohol. After treatment of 150 µl 0.1% trypsin working
solution (consisted of trypsin 0.4 ml, calcium 0.01 g, chloride
0.01 g in D.W. 7 ml) for 15 min, the sections were blocked using
FBS. For H&E staining, the sections were stained in hematoxylin
for 5 min, and then washed with water for 5 min. Then the
sections were stained in eosin for 30 s, dehydrated, and mounted
by routine methods.
Mitochondrial Microscopic Analysis
To label the mitochondria, the mature brown adipocytes were
incubated with Mito-Tracker Red probes CM-XRos (Invitrogen,
Carlsbad, CA, USA). The cells were fixed and permeabilized after
incubation in staining solution containing Mito-Tracker probe
for 30 min. Fluorescence signals were imaged using an IX71
confocal microscope (Zeiss, Germany).
Zebrafish Maintenance and Treatment
Wild type zebrafish was handled and maintained according to
the standard protocol (Kimmel et al., 1995). Larvae obtained
from daily crosses were raised and fed regular diet starting at
6 days post fertilization (dpf). Treatment of either DMSO or
CA (at 10 µM final concentration) was done for 8 days starting
from 10 to 17 dpf (n = 15 per group). To visualize adipocytes,
larvae were treated with Nile red (Sigma Chemicals, St. Louis,
MO, USA) and imaged with a Leica M165FC microscope (Leica
Microsystems, Wetzlar, Germany). The intensity of fluorescent
signals was quantified by ImageJ 1.47v (National Institute of
Health, Bethesda, MD, USA).
Cell Culture and Adipocyte
Differentiation
Cell culture, differentiation of 3T3-L1 preadipocytes (American
Type Culture Collection, Manassas, VA, USA) were performed
as previously reported (Jeong et al., 2015). Briefly, 3T3-L1 pre-
adipocytes were cultured in six-well plates until confluence in
DMEM containing 1% penicillin–streptomycin and 10% BS at
37◦C in 5% CO2 atmosphere. Two days after full confluence
(day 0), cells were stimulated to differentiate for 2 days with
differentiation inducers [0.5 mM IBMX, 1 µM Dex, 1 µg/ml
insulin (MDI)] which were supplemented to DMEM containing
25 mM glucose and 10% FBS. From day 2 to 4, the cells were
incubated with DMEM containing 10% FBS, 1 µg/ml insulin and
various concentrations of CA added to the medium. From day
4 to 6, the medium (consisting of DMEM with 10% FBS and
1 µg/ml insulin) was changed.
Brown adipocytes were obtained from the interscapular
BAT of mice (post-natal day 2) and isolated, cultured and
differentiated as previously described (Jeong et al., 2015). Briefly,
cells were grown in DMEM containing 20% FBS and 1 M
HEPES at 37◦C in a 5% CO2 atmosphere. Two days after full
confluence (day 0), were differentiated by incubation for 2 days in
differentiation media (DM), which is DMEM containing 25 mM
glucose, 0.5 mM IBMX, 0.5 µM Dex, 20 nM insulin, 125 µM
indomethacin, 1 nM T3, and 10% FBS. After 48 h (day 2), the
cells were incubated with DMEM containing 10% FBS, 20 nM
insulin, 1 nM T3, and various concentrations of CA added to the
medium. From day 4 to 6, the medium (consisting of DMEM with
10% FBS, 20 nM insulin, and 1 nM T3) was changed every 2nd
day.
MTS Cell Viability Assay
3T3-L1 preadipocytes and primary cultured brown adipocytes
were seeded in 96 well plates (2 × 104 cells/well) and incubated
for 24 h. Then the cells were incubated in 10% FBS/DMEM
medium containing CA for additional 48 h. Cell viability was
monitored by the Cell Proliferation MTS Kit (Promega Co.,
Madison, WI, USA) as recommended by the manufacturer. The
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absorbance was measured at 490 nm in a VERSAmax microplate
reader (Molecular Devices, Sunnyvale, CA, USA) to determine
the formazan concentration, which is proportional to the number
of live cells.
Oil Red O Staining
Intracellular lipid accumulation was measured using the Oil Red
O method as described by Ramirez-Zacarias et al. (1992). To
quantify the intracellular lipids, the stained lipid droplets were
dissolved in isopropanol and read for absorbance at 500 nm with
a VERSAmax microplate reader (Molecular Devices, Sunnyvale,
CA, USA).
RNA Extraction and Real-Time RT-PCR
Real-time RT-PCR analyses were performed described previously
(Jeong et al., 2015). Briefly, total RNA from tissues and cells
were isolated using a QIAzol lysis reagent (QIAGEN sciences
Inc., Venlo, Netherlands) and a GeneAllR RiboEx Total RNA
extraction kit (GeneAll Biotechnology, Seoul, Korea). Total RNA
was used as a template for first strand cDNA synthesis with
a Power cDNA synthesis kit (iNtRON Biotechnology, Seoul,
Korea), and Step One Plus Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA) was used for PCR analyses.
The primers used in the experiments are shown in Table 1.
Western Blot Analysis
Western blot analyses were performed described previously
(Jeong et al., 2015). Harvested cells were lysed with ice-cold RIPA
buffer and then centrifuged at 13,000 rpm for 20 min at 4◦C to
remove the insoluble materials. Next, the total concentration of
TABLE 1 | The primer sequences used for real-time RT-PCR.
Target gene Primer sequences
Pparg 5′-TTTCAAGGGTGCCAGTTTC-3′ (sense)
5′-TTATTCATCAGGGAGGCCAG-3′ (antisense)
Cebpa 5′-GCCGAGATAAAGCCAAACAA-3′ (sense)
5′-CGTAAATGGGGATTTGGTCA-3′ (antisense)
Glut4 5′-CGAGCTGGACGACGGACACTC-3′ (sense)
5′-AGACATAGCTCATGGCTGGAACCCG-3′ (antisense)
Lipin1 5′-TTCCTTGTCCCTGAACTGCT-3′ (sense)
5′-TGAAGACTCGCTGTGAATGG-3′ (antisense)
aP2 5′-CGTAAATGGGGATTTGGTCA-3′ (sense)
5′-TCGACTTTCCATCCCACTTC-3′ (antisense)
Sirt1 5′-AGTTCCAGCCGTCTCTGTGT-3′ (sense)
5′-GATCCTTTGGATTCCTGCAA-3′ (antisense)
Ucp1 5′-AACTGTACAGCGGTCTGCCT-3′ (sense)
5′-TAAGCCGGCTGAGATCTTGT-3′ (antisense)
Sirt3 5′-TCGAAGGAA AGATGTGGTCC-3′ (sense)
5′-ATCTGTCCTGTCCATCCAGC-3′ (antisense)
Pgc1a 5′-AATGCAGCGGTCTTAGCACT-3′ (sense)
5′-TGTTGACAAATGCTCTTCGC -3′ (antisense)
Prdm16 5′-TGGGCTCACTACCCTACCAC-3′ (sense)
5′-GACTTTGGCTCAGCCTTGAC-3′ (antisense)
Gapdh 5′-AACTTTGGCATTGTGGAAGG-3′ (sense)
5′-GGATGCAGGGATGATGTTCT-3′ (antisense)
extracted proteins was determined using the method based on
the study of Bradford (1976). The proteins in the supernatants
were separated by 8% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred onto Polyvinylidene difluoride
(PVDF) membranes. After blocking with 10 mM Tris, 150 mM
NaCl, and 0.05% Tween-20 (TBST) containing 5% skim milk
for 1 h at room temperature, the membranes were washed
with TBST and then incubated with the primary antibody at
4◦C overnight. The blots were subsequently incubated with
horseradish peroxidase (HRP)-conjugated affinipure Goat anti-
rabbit IgG (Jackson Immunoresearch lab., West Grove, PA, USA)
or HRP-conjugated affinipure Goat anti-mouse IgG (Jackson
Immunoresearch lab., West Grove, PA, USA). PVDF membranes
were purchased from Millipore (Bedford, MA, USA), and the
protein assay reagent was obtained from Bio-Rad (Hercules, CA,
USA).
Statistical Analysis
All data, expressed as mean ± standard deviation (SD), were
processed statistically by IBM SPSS Statistics 22 software
(International Business Machines Corp., New York, NY, USA).
Values with p < 0.05 were considered to indicate statistical
significance.
RESULTS
CA Improves HFD-Induced Obesity in
C57BL/6 Mice
The in vivo performance of CA was performed in male C57BL/6J
mice to determine the efficacy of administered CA. Experimental
animals appeared healthy, showing no pathological signs or
abnormalities during the feeding period. As shown in Figure 1A,
the three groups had similar body weights at the beginning of
the study. However, mice fed the HFD gained significantly more
weight than those fed the standard diet mice. On the other hand,
weight gain of CA group was significantly less than with the
untreated HFD. Mice in the HFD-group gained 23.92± 1.74 g of
weight, while those in the CA group gained 16.72± 2 g of weight
after 16 weeks. There was no difference between HFD and HFD+
CA in food intake (data not shown). Figures 1B and 2A show the
efficacy of CA on both mass and size of inguinal WAT (iWAT),
epididymal WAT (eWAT), liver, and BAT tissues.
After the 16-week experiment, plasma parameter analysis
was conducted. As shown, the level of TC, LDL-cholesterol,
triglyceride, glucose, AST, and ALT were changed significantly
(Figures 1C,D). However, there were no differences in HDL-
cholesterol levels. Furthermore, the most interesting thing was
that during the long-term of treatment with CA, ALT, and AST,
which are factors known to indicate hepatotoxicity (Yang et al.,
1997), were also brought within normal range. This indicates that
CA can ameliorate the hepatic toxicity caused by obesity.
The histological study of iWAT, liver, and BAT (Figure 2B)
showed fat accumulation in HFD-fed group. In contrast,
HFD+CA group did not show increased fat accumulation,
even though they were also fed HFD. Moreover, Pparg, Cebpa,
Lipin1, Ucp1, and Sirt3 (Schwer et al., 2002) were evaluated
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FIGURE 1 | Chrysophanic acid suppresses weight gain in HFD-induced obese C57BL/6J mice. (A) Weight changes for 16 weeks, (B) iWAT, eWAT, liver, and
BAT tissue weights were measured. (C) Total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride, glucose, (D) AST, and AST of blood serum were measured.
Data represent means ± SD. #p < 0.05 compared with NC, ∗p < 0.05 compared with HFD. NC, normal control group; HFD, high-fat diet group; HFD + CA, high-fat
diet plus CA group (n = 5 per group).
in tissues (Figures 2C–E). As in Figure 2C, there were no
significant differences by CA treatment from HFD group in
iWAT, except for the increase of Sirt1. However, Pparg and
Lipin1 were suppressed significantly in the liver (Figure 2D)
while Ucp1, Pgc1a, and Sirt3 were highly elevated in BAT
(Figure 2E).
CA Suppresses Lipid Accumulation in
Zebrafish
To further verify the in vivo effect of CA in adipocyte
development, we next examined developing zebrafish larvae after
CA treatment (Figure 3). We used the zebrafish as another in vivo
model to test the effect of CA during adipose tissue development.
Recently, development of adipose tissue in zebrafish has recently
been well characterized and also been shown to depend highly
on nutritional status (Flynn et al., 2009; Imrie and Sadler, 2010;
Minchin and Rawls, 2011). Based on the published studies, we
verified the effect of CA on zebrafish adipogenesis, which we
think highlights a robust effect of CA on adipogenesis across
species. Adipose tissues in normally developing zebrafish initially
appear in the pancreatic depot at 12 dpf followed by in the visera
at 17 dpf, subcutaneous regions at 20 dpf, and the cranium at
22 dpf (Imrie and Sadler, 2010). CA (10 µM) or DMSO as a
control was treated from 10 to 17 dpf and adipocytes of CA-
treated group compared to those of DMSO-treated control group
were examined. As shown in Figure 3, CA treatment significantly
reduced the degree of fluorescent intensity, suggesting that CA
may impair adipocyte development by suppressing accumulation
of neutral lipids in developing zebrafish larvae, consistent with
our previous in vivo results of mice.
CA Inhibits Lipid Accumulation in 3T3-L1
Adipocytes
In order to assess the cell autonomous effects of CA, further
investigations concerning in vitro models were carried out,
using 3T3-L1 adipocytes and primary cultured brown adipocytes.
To determine the cytotoxicity of CA, 3T3-L1 preadipocytes
were treated with various concentrations (1–10 µM) of CA,
after which cell viability was measured by using the MTS
assay. When measured, treatment with 1–10 µM of CA did
not cause significant cytotoxic effects for 3T3-L1 cells (data
not shown). Due to this result, further investigations were
proceeded at the specific concentrations of 1, 5, and 10 µM.
Next, to investigate the effects of CA on adipogenesis, the lipid
accumulation was measured by an Oil Red O staining assay. As
shown in Figures 4A,B, treatments with 1, 5, and 10 µM of
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FIGURE 2 | Chrysophanic acid shows inhibitory effects on adipogenesis-related factors in tissues of C57BL/6J mice. (A) Visual comparisons and
(B) H&E stainings of iWAT (magnification 200×, scale bar 100 µm), liver (magnification 200×, scale bar 100 µm), and BAT (magnification 400×, scale bar 100 µm)
were performed. Real-time RT-PCR analyses of (C) Pparg, Cebpa, and Sirt1 in iWAT, (D) Pparg, Cebpa, and Lipin1 in liver, and (E) Ucp1, Pgc1a, and Sirt3 in BAT
were performed. GAPDH was used as endogenous control. Data represent means ± SD of three independent experiments. #p < 0.05 compared with NC,
∗p < 0.05 compared with HFD. NC, normal control group; HFD, high-fat diet group; HFD + CA, high-fat diet plus CA group (n = 5 per group).
FIGURE 3 | Chrysophanic acid impairs adipocyte development in zebrafish. Zebrafish larvae treated with either DMSO (10 µM) or CA (10 µM) were shown in
lateral views with anterior to the right. Both bright-field (Left) and fluorescent images (Right) were paired to visualize the location of adipocytes detected by Nile red.
The quantification of the signal intensity from Nile red-positive adipocytes was measured by making multi-point selections of adipocytes using ImageJ. ∗p < 0.05
compared with DMSO-treated control. DMSO, DMSO-treated control group; CA, CA-treated group (n = 15 per group).
CA suppressed lipid accumulation in 3T3-L1 adipocytes with
statistical significances (p < 0.05), suggesting that CA inhibits
adipogenesis. Epigallocatechin gallate (EGCG) was used as a
positive control.
CA Down-Regulates Adipogenic Factors
in 3T3-L1 Adipocytes
Adipocyte differentiation accompanies the changes in expression
of various adipogenic and lipogenic genes such as Pparg,
Cebpa, Glut4 (Park et al., 2011), Lipin1, aP2 (Gregoire et al.,
1998), and Sirt1 (Picard et al., 2004). In order to evaluate the
effect of CA on gene expression in 3T3-L1 adipocytes, fully
differentiated 3T3-L1 cells were exposed for 48 h to various
concentrations (1, 5, and 10 µM) of CA, and the results were
compared to positive control groups, treated with EGCG or
GW9662 (GW), and a negative control group treated with
troglitazone (Trog). Expressions of adipogenic genes Pparg,
Cebpa, Glut4, Lipin1, and aP2 were significantly decreased by
CA (Figures 4C,D). In addition, CA significantly increased the
expression of Sirt1 in a dose-dependent manner (Figure 4E). CA
Frontiers in Pharmacology | www.frontiersin.org 6 December 2016 | Volume 7 | Article 476
fphar-07-00476 December 7, 2016 Time: 11:7 # 7
Lim et al. CA Regulates Adipogenesis/Thermogenesis via AMPK
FIGURE 4 | Chrysophanic acid suppresses adipogenic factors in 3T3-L1 adipocytes. (A) An Oil Red O analysis was performed in order to measure the lipid
accumulation (magnification 200×, scale bar 100 µm). (B) Relative optic density was measured at 500 nm. Real-time RT-PCR analyses of (C) Pparg, Cebpa,
(D) Glut4, Lipin1, aP2, and (E) Sirt1 were performed. EGCG (10 µM) and GW (10 µM) were used as positive controls. Trog (10 µM) was used as a negative control.
GAPDH was used as endogenous control. Data represent means ± SD of three independent experiments. #p < 0.05 compared with MDI-uninduced preadipocytes,
∗p < 0.05 compared with MDI-induced adipocytes. MDI, differentiation medium.
treatment also suppressed PPARγ and C/EBPα at the protein
levels (Figures 5A,B). To further demonstrate the effects of CA,
we co-treated CA with PPARγ agonists or antagonists during
the adipogenesis process of 3T3-L1 adipocytes (Figures 5C,D).
PPARγ was decreased by CA; whether as a sole treatment, or
used together with the PPARγ antagonist, GW. In addition, CA
significantly nullified the effect of Trog which implies that CA can
compete against the activated adipogenesis by Trog, the PPARγ
agonist.
CA Induces Thermogenic Factors in
Primary Cultured Brown Adipocytes
Through the mice experiment results, we could infer the probable
interaction between CA and BAT. To certify the interaction
between CA and brown adipocytes, we conducted experiments
on primary cultured brown adipocytes. To determine the
cytotoxicity of CA in brown adipocytes, they were treated with
CA at various concentrations (1–10 µM) and the cell viability
was measured by the MTS assay. Due to the result, further
investigations were proceeded at the specific concentrations of 1,
2, and 4 µM (Figure 6A).
Since the activity and number of mitochondria is a
typical difference between white and brown adipocytes, the
mitochondrial abundance was also analyzed using Mito-Tracker
fluorescence images. As shown in Figure 6B, CA-treated cells
showed stronger staining than in control cells in a concentration-
dependent manner.
To investigate the efficacy of CA in thermogenesis activation
of brown adipocytes, thermogenic genes Ucp1, Pgc1a (Puigserver
et al., 1998), and Prdm16, the transcription factor of brown
fat (Seale et al., 2007), were evaluated. Figure 6C shows
significant effects of CA on gene expressions in brown adipocytes.
Additionally, UCP1 and PGC1α were increased significantly
at the protein levels as well (Figures 6D,E). Resveratrol
(RSV), a nature-derived compound reported to activate BAT
thermogenesis (Andrade et al., 2014) was used as positive control.
CA Suppresses Adipogenesis and
Induces Thermogenesis via Activation of
AMPK Pathway
As CA showed elevated SIRT1 and SIRT3 levels in vivo and
in vitro, its possibility as an AMPK activator led us to additional
investigation concerning the effects of CA on the AMPK pathway.
The relationship between SIRT1 and AMPK is already well
reported (Ruderman et al., 2010), and SIRT3, another protein
belonging to the sirtuin family, also activates AMPK and PGC1α
as well (Palacios et al., 2009). Additionally AMPK, a key player in
energy homeostasis (Lowell, 1999), was activated by CA during
adipocyte differentiation, when the level of phosphorylated
AMPKα was analyzed and compared with the total level of
AMPKα. When compared with the control group, AMPKα
phosphorylation was increased in a dose-dependent manner
of CA treatment (Figure 7A), while the total AMPKα was
unchanged.
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FIGURE 5 | Chrysophanic acid suppresses PPARγ in competition against the PPARγ agonist troglitazone in 3T3-L1 adipocytes. (A) Western blot
analyses of PPARγ and C/EBPα were performed and (B) quantification of the protein bands was measured using ImageJ. (C) Western blot analysis of PPARγ was
performed under co-treatment of CA with GW or Trog, and (D) quantification of the protein bands was measured using ImageJ. EGCG (10 µM) and GW (10 µM)
were used as positive controls. Trog (10 µM) was used as a negative control. GAPDH was used as endogenous control. Data represent means ± SD of three
independent experiments. #p < 0.05 compared with MDI-uninduced preadipocytes, ∗p < 0.05 compared with MDI-induced adipocytes. MDI, differentiation medium.
In Figure 7B, Compound C (CC), the AMPK inhibitor,
suppressed activation of AMPK, resulting in increased protein
levels of PPARγ and C/EBPα. Under inhibited AMPK conditions
by CC treatment, the suppressing action of CA on these proteins
was nullified. Additional experiments concerning CC were
performed in primary cultured brown adipocytes (Figure 7C).
Similar to the results from 3T3-L1 cells, by blocking AMPK
activation, CA failed to increase the expression of PGC1α.
Through these results, we could confirm the anti-obese effect
of CA by inhibiting adipogenesis in WAT and inducing
thermogenesis in BAT was partially via activation of the AMPK
pathway.
DISCUSSION
Anti-obesity drugs currently available are plagued with inefficacy
and side-effects ranging from mild to potentially harmful (Gooda
Sahib et al., 2012; Rodgers et al., 2012). Consequently, the use
of natural products to combat obesity is rapidly increasing.
Research to identify targets from natural and alternative
sources for development into clinical treatments against obesity
is gaining momentum (Gooda Sahib et al., 2012). CA, a
yellow crystalline substance extracted from rhubarb, which
is frequently used in Korean Medicine for various purposes
including treatment for obesity. Despite the facts previous
studies have shown numerous effects of CA, not one study
involving anti-obesity effects of CA has been reported to
date.
Obesity is defined as increased adipose accumulation of excess
energy resulting from imbalance between intake and expenditure
of energy (Stunkard, 1996). C57BL/6 mice fed with HFD is a
widely used experimental model for obesity research. Although
genetically engineered mice models such as ob/ob (mice unable
to produce leptin) or db/db (mice unable to respond to leptin)
are available for obesity research, they lack convincing evidence
for whether leptin-related mutation can represent typical obesity
in humans (Wang et al., 2014). As shown by Lin et al. (2000),
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FIGURE 6 | Chrysophanic acid upregulates brown-fat-specific factors at both mRNA and protein levels in primary cultured brown adipocytes. (A) An
MTS assay was performed to measure the survival rate of primary cultured brown adipocytes after treatment with CA. (B) Mitochondrial abundance in primary brown
adipocytes was analyzed by MitoTracker Red staining (magnification 200×, scale bar 100 µm). (C) Real-time RT-PCR analyses of Ucp1, Pgc1a, and Prdm16 were
performed. (D) Western blot analyses of UCP1 and PGC1α were performed. (E) Quantification of the protein bands was measured using ImageJ. RSV (500 nM) was
used as a positive control. GAPDH was used as endogenous control. Data represent means ± SD of three independent experiments. #p < 0.05 compared with
DM-uninduced preadipocytes, ∗p < 0.05 compared with DM-induced adipocytes. DM, differentiation medium.
long-term HFD administration in C57BL/6 mice results in
obesity development, showing increased body weight gain and
fat accumulation. We conducted an in vivo model referring
this report, in order to evaluate the anti-obese effect of CA.
As a result, CA treatment successfully inhibited weight gain,
lipid accumulation in WATs, liver, and BAT. It also ameliorated
obese- and hepatotoxic-related changes in serum caused by HFD
administration. Assays regarding mRNA expressions in tissues
showed decreased expressions of adipogenic genes such as Pparg,
Cebpa, Sirt1, and Lpin1, while thermogenic genes including Ucp1
and Pgc1a were increased.
PPARγ and C/EBPα are key transcription factors in
adipogenesis of 3T3-L1 cells (Lee et al., 2011). C/EBPβ is induced
immediately after differentiation, whereas C/EBPα and PPARγ
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FIGURE 7 | Chrysophanic acid induces AMPK phosphorylation
resulting in inhibition of adipogenesis in 3T3-L1 adipocytes and
activation of thermogenesis in primary cultured brown adipocytes.
(A) Western blot analyses of p-AMPKα and AMPKα were performed in
CA-treated 3T3-L1 adipocytes. (B) Western blot analyses of p-AMPKα and
AMPKα were performed under co-treatment of CA and CC in 3T3-L1
adipocytes. (C) Western blot analyses of p-AMPKα and AMPKα were
performed under co-treatment of CA and CC in primary cultured brown
adipocytes. The phosphorylation level of AMPKα was measured by
p-AMPKα/AMPKα rate. GAPDH was used as endogenous control. Data
represent means ± SD of three independent experiments. #p < 0.05
compared with MDI- or DM-uninduced preadipocytes, ∗p < 0.05 compared
with MDI- or DM-induced adipocytes. MDI and DM, differentiation medium.
are expressed much later (Cristancho and Lazar, 2011). They are
necessary for the expression of adipocyte-specific genes, which
lead to morphological changes and lipid accumulation within
the cells. CA treatment successfully inhibited the expressions
of these key adipogenic factors, PPARγ and C/EBPα, both in
the in vivo model of HFD-induced obese mice and the in vitro
adipocyte model, 3T3-L1 cells. Lipin is shown to be involved
in various pathways regarding lipid metabolism in diverse cell
types such as liver, adipose tissues, muscle, and neuronal cells
(Phan and Reue, 2005; Finck et al., 2006; Reue and Zhang,
2008). Depletion of LIPIN1 gene in preadipocytes delays fat
cell differentiation, showing the importance of adipose-specific
lipin-1 function in lipid homeostasis (Chen et al., 2008; Koh
et al., 2008). Adipocyte fatty-acid-binding protien 2 (aP2) is a
cytoplasmic chaperone which plays critical roles in several lipid
signals (Tuncman et al., 2006). CA treatment decreased these
lipogenic factors during the differentiation process in 3T3-L1
adipocytes.
Brown adipocytes are equipped with abundant mitochondria
and uniquely express UCP1, which can dissipate the proton
gradient of the inner mitochondrial membrane that is formed
as a result of oxidative phosphorylation of nutrients. This
process, also known as non-shivering thermogenesis, generates
heat instead of ATP production (Cannon and Nedergaard, 2010).
The transcriptional control network of brown adipogenesis has
been analyzed and reviewed in detail elsewhere (Vernochet
et al., 2010). In brief, the transcription factors PPARγ and
C/EBPs including C/EBPα/β/δ have been established as essential
parts of the differentiation of adipocytes. It is generally
accepted that these transcription factors direct the differentiation
of both brown and white adipocytes. The transcriptional
events specifying brown adipogenesis are regulated by the
nuclear co-activator PGC1α (Puigserver et al., 1998) and the
transcription factor PRDM16, which physically interacts with
C/EBPβ (Kajimura et al., 2009). Interestingly, recent evidence
suggests that modulators of PPARγ-binding activity may specify
brown adipogenic lineage transcriptional activity (Qiang et al.,
2012). This modification is essential for recruitment of PRDM16
to PPARγ and initiation of the brown-fat-specific program
(Qiang et al., 2012). CA was able to decrease lipid accumulation
and increase Ucp1, Pgc1a, and Sirt3 gene expressions in
BAT of HFD-fed mice. Furthermore, in primary cultured
brown adipocytes, CA treatment showed increased levels of
mitochondria. Thermogenic factors including UCP1 and PGC1α
were also up-regulated by CA treatment at both mRNA
and protein levels as well, implying the thermogenic features
of CA.
In differentiated fat cells, up-regulated SIRT1 promotes
lipolysis resulting in loss of fat mass (Picard et al., 2004).
Activation of the NAD+-dependent deacetylase SIRT1 by
therapeutic small molecules, caloric restriction or exercise
promotes mitochondrial biogenesis and activities (Milne et al.,
2007), raising the possibility that SIRT1 can regulate BAT
functions. SIRT1 and AMPK form a close relationship in
the energy metabolic mechanism (Ruderman et al., 2010),
and furthermore, AMPK is activated during cold exposure
in C57BL/6 mice (Mulligan et al., 2007), implying the link
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between AMPK and BAT. Not only this, AMPK activation
increases expressions of mitochondria-related genes through
PGC1α expression (Jager et al., 2007). These previous reports
support the relationship of AMPK and BAT activation. Our
results showed that CA can suppress adipogenic factors in 3T3-
L1 murine white adipocytes while it can increase thermogenic
factors in primary cultured brown adipocytes. Though more
investigation is required in order to reveal the exact mechanism,
our results show that this multi-functioning effect of CA is
possibly via the AMPK pathway as both features were nullified
when AMPK activation was inhibited by CC treatment.
In the present study, we observed how the CA works on
obese mice. The body weight, iWAT weight, eWAT weight, and
liver weight was remarkably decreased in the CA administrated
group. Furthermore, we discovered histological changes. The
CA group was fed with HFD, same as the HFD-induced obese
group, but by CA treatment, the morphology of WAT and BAT
seemed like those of the NC group. The brown-fat-specific genes
were also increased in BAT. The anti-adipogenic features of CA
were confirmed using the zebrafish in vivo model. Then, we
demonstrated that CA inhibited adipogenesis in 3T3-L1 cells.
CA controlled adipogenesis factors, and interestingly, 3T3-L1
adipocytes co-treated with CA and Trog showed significantly
nullified effect of Trog. This shows that CA is able to compete
against PPARγ agonists. We also proved the effect of CA on
thermogenic factors using primary cultured brown adipocytes.
As expected, CA influenced primary cultured brown adipocytes
by upregulating several thermogenic factors including UCP1,
PGC1α, and PRDM16. Not only this, mitochondrial content was
increased by CA treatment. From the increased levels of SIRT1
and SIRT3 in previous experiments, we hypothesized CA could
affect AMPK activation. As expected, AMPK phosphorylation
was increased by CA in 3T3-L1 cells. Furthermore, when we
inhibited AMPK activation by CC pre-treatment, CA did not
work properly in both 3T3-L1 adipocytes and primary cultured
brown adipocytes. Through these results, we could discover that
CA has anti-obesity effects in vivo and in vitro, and furthermore,
were able to confirm the anti-obese effect was due to the
activating effect of CA on the AMPK pathway.
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